Case Report: Personalized treatment in an advanced lung adenocarcinoma patient with EGFR exon 21 L858R mutations based on the patient-derived tumor organoids - Quiz - MDSpire

Case Report: Personalized treatment in an advanced lung adenocarcinoma patient with EGFR exon 21 L858R mutations based on the patient-derived tumor organoids

  • By

  • Fan Zhang

  • Yuxiang Wang

  • Xi Zhang

  • Yuting Bai

  • Li Zhang

  • Shuqing Wei

  • May 12, 2026

  • 0 min

Share

Original Source(s)

Case Report: Personalized treatment in an advanced lung adenocarcinoma patient with EGFR exon 21 L858R mutations based on the patient-derived tumor organoids

  • by Fan Zhang, Yuxiang Wang, Xi Zhang, Yuting Bai, Li Zhang, Shuqing Wei

  • May 12, 2026

Related Content

FOXA2 in cancer: from fundamental biology to clinical translation

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

Management of toxicities from antibody – drug conjugates in breast cancer